SOPHARMA (SPH): Notification - raport 44
UNI - EN REPORT No44/2016
The Board of Directors of SOPHARMA AD (the “Company”) hereby informs that for April 2016 Sopharma AD realized a decrease of sales revenues of 19% compared to the same month of last year, including retention of the level of domestic sales and 29% decrease of export sales.
For the first four months of 2016 sales revenues decreased by 4% compared to the same period of 2015, including a 6% increase of domestic sales and a 10% decrease of export sales. In the past two months there has been a sharp decline in the purchasing power of the population in Russia and conservative use of resources by households as the indexation of the prices has outpaced the indexation of wages. We expect that this trend will continue in the summer months, which are traditionally weak.
